JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total International Bond ETF
BNDX
|
+$2.3B |
| 2 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$1.64B |
| 3 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.55B |
| 4 |
iShares MBS ETF
MBB
|
+$1.29B |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.14B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$693M |
| 2 |
CVS Health
CVS
|
+$676M |
| 3 |
Johnson & Johnson
JNJ
|
+$669M |
| 4 |
Mondelez International
MDLZ
|
+$593M |
| 5 |
UnitedHealth
UNH
|
+$572M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.25% |
| 2 | Technology | 12.49% |
| 3 | Financials | 12.17% |
| 4 | Healthcare | 9.9% |
| 5 | Consumer Discretionary | 8.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
5401
Grupo SIMEC
SIM
| $6K | ﹤0.01% |
670
| – | – |
2015 Q4
13 quarters
|
|
5402
Invesco Solar ETF
TAN
$903M
| $6K | ﹤0.01% |
250
| – | – |
2017 Q2
7 quarters
|
|
|
HARP
5403
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
| $6K | ﹤0.01% |
+62
| New | +$8.15K |
2019 Q1
0 quarters
|
|
|
RADA
5404
DELISTED
Rada Electronic Industries Ltd
RADA
| $6K | ﹤0.01% |
+2,100
| New | +$5.72K |
2019 Q1
0 quarters
|
|
|
MLNT
5405
DELISTED
Melinta Therapeutics, Inc. Common Stock
MLNT
| $6K | ﹤0.01% |
1,869
-53,392
| -97% | -$290K |
2017 Q4
5 quarters
|
|
5406
iShares MSCI Ireland ETF
EIRL
$76.2M
| $5K | ﹤0.01% |
121
| – | – |
2013 Q2
23 quarters
|
|
5407
First Trust Exchange-Traded Fund IV First Trust Tactical High Yield ETF
HYLS
$1.57B
| $5K | ﹤0.01% |
100
-618
| -86% | -$29.2K |
2015 Q2
15 quarters
|
|
5408
Mizuho Financial
MFG
$132B
| $5K | ﹤0.01% |
1,498
-90,889
| -98% | -$285K |
2013 Q2
23 quarters
|
|
5409
Nomura Holdings
NMR
$28.4B
| $5K | ﹤0.01% |
1,157
-300
| -21% | -$1.17K |
2018 Q3
2 quarters
|
|
5410
Invesco CEF Income Composite ETF
PCEF
$776M
| $5K | ﹤0.01% |
214
+3
| +1% | +$65 |
2015 Q4
13 quarters
|
|
5411
Purple Innovation
PRPL
$9.16M
| $5K | ﹤0.01% |
45
-10
| -18% | -$1.38K |
2018 Q3
2 quarters
|
|
|
SCPH
5412
DELISTED
scPharmaceuticals
SCPH
| $5K | ﹤0.01% |
1,738
-123
| -7% | -$422 |
2018 Q1
4 quarters
|
|
|
DAY
5413
DELISTED
Dayforce
DAY
| $5K | ﹤0.01% |
97
| – | – |
2018 Q2
3 quarters
|
|
|
AGRX
5414
DELISTED
Agile Therapeutics
AGRX
| $5K | ﹤0.01% |
+2
| New | +$4.24K |
2019 Q1
0 quarters
|
|
|
ICOL
5415
DELISTED
iShares MSCI Colombia ETF
ICOL
| $5K | ﹤0.01% |
400
| – | – |
2017 Q3
6 quarters
|
|
|
RWSL
5416
DELISTED
Direxion Russell Small Over Large Cap ETF
RWSL
| $5K | ﹤0.01% |
+100
| New | +$5.31K |
2019 Q1
0 quarters
|
|
|
SAEX
5417
DELISTED
SAExploration Holdings, Inc.
SAEX
| $5K | ﹤0.01% |
1,456
| – | – |
2018 Q3
2 quarters
|
|
|
WFT
5418
DELISTED
Weatherford International plc
WFT
| $5K | ﹤0.01% |
6,550
-662,772
| -99% | -$459K |
2014 Q3
18 quarters
|
|
5419
First Trust Mid Cap Growth AlphaDEX Fund
FNY
$573M
| $4K | ﹤0.01% |
+94
| New | +$3.9K |
2019 Q1
0 quarters
|
|
|
FPAY
5420
DELISTED
FlexShopper
FPAY
| $4K | ﹤0.01% |
5,000
| – | – |
2016 Q4
9 quarters
|
|
5421
First Trust Industrials/Producer Durables AlphaDEX Fund
FXR
$694M
| $4K | ﹤0.01% |
100
-30
| -23% | -$1.15K |
2017 Q1
8 quarters
|
|
5422
PUT
Geron
GERN
$771M
| $4K | ﹤0.01% |
+2,200
| New | +$3.01K |
2019 Q1
0 quarters
|
|
5423
ProShares Trust UltraShort Lehman 7-10 Year Treasury
PST
$11.4M
| $4K | ﹤0.01% |
200
| – | – |
2018 Q4
1 quarter
|
|
5424
Invesco Energy Exploration & Production ETF
PXE
$88.1M
| $4K | ﹤0.01% |
219
| – | – |
2017 Q1
8 quarters
|
|
|
RDHL
5425
Redhill Biopharma
RDHL
$4.44M
| $4K | ﹤0.01% |
+1
| New | +$7.91K |
2019 Q1
0 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2019 Portfolio in Review
As of Q1 2019, JP Morgan Chase held 6,314 positions worth $490B, up 13% from $432B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q1 2019 filing shows 537 new, 2,080 increased, 2,670 reduced and 537 closed positions. Its largest new stake was Lyft: 2,510,596 shares worth $197M. The largest sale was Apple, an estimated $693M.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, up from 26% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q1 2019 buy was Lyft: 2,510,596 shares worth $197M.
- JP Morgan Chase added most to Vanguard Total International Bond ETF in Q1 2019, an estimated $2.3B increase.
- JP Morgan Chase's biggest Q1 2019 reduction was Apple, cutting an estimated $693M.
- JP Morgan Chase fully exited Twenty-First Century Fox, Inc. Class A in Q1 2019, selling an estimated $164M.
- JP Morgan Chase's ten largest holdings make up 16% of its $490B portfolio in Q1 2019.
- JP Morgan Chase opened 537 new positions and closed 537 in Q1 2019.
- JP Morgan Chase's portfolio value rose 13% quarter-over-quarter to $490B.
Based on JP Morgan Chase's 13F filing for Q1 2019, filed 7 May 2019.